tech
Prime Radiant Invests $50 Million in Cellares Before 2027 IPO
Upstart private equity firm Prime Radiant Partners is investing $50 million in Cellares, as the biotechnology company making high-tech robots to mass-produce cancer treatments raises money ahead of a potential initial public offering in 2027.
Read full story on Bloomberg Tech → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Tech alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop